By Jeff Overley ( June 11, 2012, 4:52 PM EDT) -- A Delaware judge on Monday kept alive a shareholder derivative suit seeking to hold Botox manufacturer Allergan Inc.'s board liable for a $600 million settlement with the U.S. Department of Justice over off-label Botox use, saying the dismissal of a related case shouldn't count against investors....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.